• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CRL
Click for more information
0.00% 2.0¢

COMET RESOURCES LIMITED

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
CRL
Ann: Half Year Accounts 		14/03/19 0 245
14/03/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  245 
CRL
Ann: Notice of General Meeting/Proxy Form 		01/03/19 0 175
01/03/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  175 
CRL
Ann: Drilling Commences at Springdale Graphite Project 		01/03/19 0 208
01/03/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  208 
CRL
Ann: Appendix 3B 		26/02/19 0 277
26/02/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  277 
CRL
Ann: CRL Investor Presentation - RIU explorers conference 		21/02/19 0 217
21/02/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  217 
CRL
Ann: Initial Director's Interest Notice 		15/02/19 0 361
15/02/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  361 
CRL
Ann: COMET ATTRACTS HIGH PROFILE MINING EXECUTIVE TO ITS BOARD 		15/02/19 0 464
15/02/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  464 
CRL
Ann: Quarterly Activities Report and Appendix 5B Dec 2018 		31/01/19 0 292
31/01/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  292 

See All Discussions arrow Created with Sketch.

Top Stories

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
HotCopper Highlights: Your most watched stocks for Week 46, 2024 What you - HotCopper users - were most interested in viewing and discussing this week (Week 46 of the year!)
To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels Put simply: if 3D Printing is a gold rush, Amaero is selling shovels. Or maybe it's more like sneakers in an arms race.
Banshee's historic trenches prove rich in antimony and gold for GDM Great Divide Mining Ltd has found high-grade antimony and gold through geochemical sampling at its Banshee prospect in Queensland
Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.